CVE-2023-32069

XWiki Platform privilege escalation (PR)/RCE from account through class sheet

Description

XWiki Platform is a generic wiki platform. Starting in version 3.3-milestone-2 and prior to versions 14.10.4 and 15.0-rc-1, it's possible for a user to execute anything with the right of the author of the XWiki.ClassSheet document. This has been patched in XWiki 15.0-rc-1 and 14.10.4. There are no known workarounds.

Category

9.9
CVSS
Severity: Critical
CVSS 3.1 •
EPSS 3.06% Top 15%
Vendor Advisory github.com Vendor Advisory xwiki.org
Affected: xwiki xwiki-platform
Published at:
Updated at:

References

Link Tags
https://github.com/xwiki/xwiki-platform/security/advisories/GHSA-36fm-j33w-c25f vendor advisory
https://github.com/xwiki/xwiki-platform/commit/de72760d4a3e1e9be64a10660a0c19e9534e2ec4 patch
https://jira.xwiki.org/browse/XWIKI-20566 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2023-32069?
CVE-2023-32069 has been scored as a critical severity vulnerability.
How to fix CVE-2023-32069?
To fix CVE-2023-32069, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-32069 being actively exploited in the wild?
It is possible that CVE-2023-32069 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~3% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-32069?
CVE-2023-32069 affects xwiki xwiki-platform.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.